Latest osteosarcoma Stories
Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer.
James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr. Wittig, an orthopedic oncologist with extensive experience in performing limb-sparing surgeries, is Chief of the Division of Skin and Sarcoma Cancer of the John Theurer Cancer Center at Hackensack University Medical Center.
HACKENSACK, N.J., Oct. 4 /PRNewswire/ -- James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr.
NEW YORK, Aug. 6 /PRNewswire/ -- The Bone and Cancer Foundation (BCF) is announcing the publishing of two new patient publications on Pain Management and Physical Therapy and other Rehabilitation Therapies.
HIGH WYCOMBE, England, July 9, 2010 /PRNewswire/ -- - In a draft appraisal the National Institute for Health and Clinical Excellence (NICE) has refused to recommend the first treatment shown to improve survival in childhood bone cancer (osteosarcoma) in more than 20 years(1,2) - Data shows Mepact(R) (mifamurtide) reduces the risk of death by almost one third when added to standard chemotherapy treatment, compared with chemotherapy alone(3) - Using...
WILTON, Conn., and SAN DIEGO, April 30 /PRNewswire/ -- Cancer is the number-one disease-related cause of death among dogs and cats. For the month of May, PETCO and Blue Buffalo are partnering to raise awareness and funds to fight this devastating disease.
NEW YORK, April 29 /PRNewswire-USNewswire/ -- The Sarcoma Foundation of America (SFA)'s Eighth Annual Fundraising Gala on Monday, April 26, raised more than $925,000, an all-time record for the non-profit group dedicated to increasing research that will find new and better therapies for patients with sarcoma, a rare connective tissue cancer.
Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows.
TGen and VARI study cancer in dogs to find new treatments for humans.
Dr. Tsz-Kwong Man, a researcher with the Texas Children's Cancer Center at Baylor College of Medicine, has a received a grant from the Liddy Shriver Sarcoma Initiative to study the function of a protein that may promote the spread of a common form of children's bone cancer called osteosarcoma.
- An armed gangster.